Search Results 1601-1610 of 21865 for Inhibition

1. A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma - Mayo Clinic

   ... inhibitor. Additional Inclusion Criteria for Cohort B2 (R/R FL or MZL): ... inhibitors, which cannot be discontinued within 5 half-lives of the first ...

2. SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Have received prior therapy with an immunomodulatory agent, a proteosome inhibitor, and glucocorticoids ... inhibitors; or are receiving treatment with agents ...

3. Publications - Bently Doonan, M.D., M.S. - Mayo Clinic

   Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has ... inhibition of calpain in PBMCs from MS patients. J Neuroimmunol. 2011 Mar ...

4. A Study of The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension)

   Concurrent use of any non-insulin glucose-lowering agent other than metformin (including GLP-1 agonists, Symlin, DPP-4 inhibitors, SGLT-2 inhibitors, ...

5. Phase 1b Open-Label Study of PEGPH20 With Pembrolizumab - Mayo Clinic

   ... inhibitor and subjects known to be anaplastic lymphoma kinase (ALK)-mutation positive must have received an ALK inhibitor. Prior to enrollment, confirmation ...

6. Kratom: Unsafe and ineffective - Mayo Clinic

   Angiotensin-converting enzyme (ACE) inhibitors · Antidepressant withdrawal: Is there such a thing? Antidepressants and alcohol: What's the concern ...

7. Study Of Sacituzumab Govitecan-hziy And Pembrolizumab Versus Treatment Of Physician's Choice In Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery And Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) - Mayo Clinic

   * Prior treatment with topoisomerase 1 inhibitors or antibody-drug conjugates (ADCs) containing a topoisomerase inhibitor. * Individuals with germline ...

8. A Phase I/II Study Of AZD4512 Monotherapy Or In Combination With Anticancer Agents In Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   Mantle cell lymphoma (MCL) patients must have had anti-CD20 and Bruton's Tyrosine Kinase (BTK) inhibitor. ... inhibitors or (corrected QT interval ...

9. Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion - Mayo Clinic

   use of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention ... Strong CYP3A4 and P-glycoprotein inhibitor use which increase ...

10. New and novel treatments for hyperlipidemia - Mayo Clinic

    Statins lower cholesterol by inhibition of HMG-CoA reductase, the rate ... inhibition of cholesterol biosynthesis. The Nobel Prize-winning work of ...